Recent Posts
- CABA-201 gets FDA orphan drug status as scleroderma treatment
- How scleroderma has changed my face, despite my best efforts
- T-helper cells may affect lung disease severity in SSc: StudyÂ
- Joint inflammation, health-related quality of life linked in SSc: Study
- Cognitive difficulties, malnutrition can be common with scleroderma
- Frequency of muscle disease in SSc shows need for biomarkers: Study
- FDA fast track designation granted to Certa’s FT011 for scleroderma
- As symptoms of scleroderma speak, I reply, ‘Now what?’
- Conversation, activities reduced SSc patients’ loneliness in pandemic
- Investigational treatment named US, EU orphan drug for scleroderma